FARAPULSE™ is transforming clinical leadership in #PulsedFieldAblation. To-date, FARAPULSE™ is the most-proven PFA system, reshaping treatment for paroxysmal #AFib. https://t.co/FrmpuxdSGK
Safety info: https://t.co/mfRytm4lTm
We currently have opportunities available across 4 of our 7 research centres: Research Assistant, Genetic Counsellor, Research Officer & Computational Scientist. For more info & to apply visit: https://t.co/PBWQGD1SAy #medicalresearch#centenaryinstitute
Leading tissue-selective ablation in over 40,000 #AF patients, the FARAPULSE #PFA System is extremely validated by clinical evidence and real-world experience.
Find out more by downloading our new version of the clinical compendium which includes 2023 clinical publications.
The FARAPULSE™ Pulsed Field Ablation System is now FDA approved! This innovative technology will accelerate the growth of our electrophysiology portfolio and enable physicians to treat more patients with #AFib worldwide. #PulsedFieldAblation Learn more: https://t.co/ACClFksiOD
The FARAPULSE™ Pulsed Field Ablation System is now FDA approved! FARAPULSE™ offers tissue selective cardiac #ablation for the treatment of PAF which minimizes thermal risk. See the FARAPULSE™ difference: https://t.co/ch1o7AcENY
Safety info: https://t.co/gRtvxWHcGw
The AVANT GUARD clinical trial has commenced and will evaluate the safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation System as a first-line treatment for persistent atrial fibrillation (AF). Learn more: https://t.co/Ikcyxj72Ba
Super proud of our team for running our first APAC Meet the Masters event since 2019 this past weekend with 40 EP fellows from the APAC region in attendance. Big thanks to our faculty. @mdjunkim@EP_satomi@Dr_GwilymMorris@drjyschan Prof. Lo & Prof. Chung
Presented at #TCT2023 | REAL-PE, a study of over 2200 real-world #PE patients treated with #EKOS or FlowTriever—EKOS showed a statistically significant lower rate of major bleeding than patients treated with FlowTriever. Learn more: https://t.co/EjvgX8UtGJ
Just in from #ESCCongress! FARAPULSE™ Pulsed Field Ablation System has met all end points for primary safety and efficacy in the ADVENT Pivotal Trial and been shown to be non-inferior to standard-of-care thermal ablation (RF and Cryo)Just in from #ESCCongress! FARAPULSE™ Pulsed Field Ablation System has met all end points for primary safety and efficacy in the ADVENT Pivotal Trial and been shown to be non-inferior to standard-of-care thermal ablation (RF and Cryo)Just in from #ESCCongress! FARAPULSE™ Pulsed Field Ablation System has met all end points for primary safety and efficacy in the ADVENT Pivotal Trial and been shown to be non-inferior to standard-of-care thermal ablation (RF and Cryo)Just in from #ESCCongress! FARAPULSE™ Pulsed Field Ablation System has met all end points for primary safety and efficacy in the ADVENT Pivotal Trial and been shown to be non-inferior to standard-of-care thermal ablation (RF and Cryo)Just in from #ESCCongress! FARAPULSE™ Pulsed Field Ablation System has met all end points for primary safety and efficacy in the ADVENT Pivotal Trial and been shown to be non-inferior to standard-of-care thermal ablation (RF and Cryo)Just in from #ESCCongress! FARAPULSE™ Pulsed Field Ablation System has met all end points for primary safety and efficacy in the ADVENT Pivotal Trial and been shown to be non-inferior to standard-of-care thermal ablation (RF and Cryo).
In a first for SA, cardiologists at the Royal Adelaide Hospital have successfully used a new state-of-the-art procedure to correct common heart rhythm disorders, such as atrial fibrillation.
Read more 👉 https://t.co/dzqSTIhNKS
#WorldClass#Adelaide
@ProfRScolyerMIA @DrZembowicz@ProfGLongMIA @ProfRScolyerMIA you are one of the strongest and not just in the medical field. Sending you strength and support